Options Prospectus
Released
Released
Announcement PDF
Prospectus
RareX Limited
(ACN 105 578 756)
This Prospectus is being issued for the offer of:
(a) up to 61,363,636 Quoted Options to May Placement Participants, on the basis of one (1)
free-attaching Quoted Option for every two (2) May Placement Shares subscribed for and
issued under the May Placement (May Placement Options Offer); and
(b) up to 45,454,545 Quoted Options to July Placement Participants, on the basis of one (1)
free-attaching Quoted Option for every two (2) July Placement Shares subscribed for and
issued under the July Placement (July Placement Options Offer),
(together, the Offers).
ASX Code
REE
Important Notice
This is an important document and requires your immediate attention. It should be read in its entirety.
If you are in doubt about what to do, you should consult your professional adviser without delay.
An investment in the Quoted Options offered in connection with this Prospectus should be considered
of a speculative nature.
i
Table of contents
Corporate directory 1
Capital structure 3
1. Background to the Offers 6
1.1 May Placement 6
1.2 July Placement 6
1.3 The Offers 7
1.4 Conditional Offers 8
1.5 Purpose of this Prospectus 8
1.6 Opening and Closing Date 8
1.7 Minimum subscription 9
1.8 No underwriting 9
1.9 No rights trading 9
1.10 Application Forms 9
1.11 Issue date and dispatch 10
1.12 ASX quotation 10
1.13 CHESS 10
1.14 Residents outside Australia 11
1.15 Taxation implications 12
1.16 Major activities and financial information 13
1.17 Privacy 13
1.18 Enquiries concerning this Prospectus 13
2. Effect of the Offers 14
2.1 Capital structure on completion of the Offers 14
2.2 Proposed use of funds 2
2.3 Effect on control of the Company 2
2.4 Substantial Shareholders 2
2.5 Financial effect of the Offers 2
3. Risk factors 4
3.1 Risks specific to the Company 4
3.2 Mining industry risks 7
3.3 General risks 11
4. Rights attaching to Securities 14
4.1 Rights and liabilities attaching to Shares 14
4.2 Terms and conditions of Quoted Options 15
5. Additional information 18
5.1 Company is a disclosing entity 18
5.2 Copies of documents 18
ii
5.3 Information excluded from continuous disclosure notices 19
5.4 Determination by ASIC 19
5.5 Market price of Shares 19
5.6 Dividend Policy 19
5.7 Interests of Directors 19
5.8 Related party transactions 22
5.9 Interests of other persons 22
5.10 Expenses of Offers 22
5.11 Consents 22
5.12 Electronic Prospectus 23
6. Directors’ statement and consent 24
7. Definitions 25
1
Important information
General
This Prospectus is issued by RareX Limited
(ACN 105 578 756) (Company or RareX) for
the purposes of Chapter 6D of the Corporations
Act. This Prospectus is dated 20 October 2025
and was lodged with the ASIC on that date with
the consent of all Directors. Neither ASIC nor
ASX nor their respective officers take any
responsibility for the contents of this
Prospectus.
No Quoted Options will be issued on the basis
of this Prospectus any later than 13 months
after the date of this Prospectus (being the
expiry date of this Prospectus).
Application will be made to the ASX within
seven days after the Prospectus Date for
quotation of the Quoted Options the subject of
this Prospectus.
The Quoted Options offered by this Prospectus
should be considered speculative. Please refer
to Section 3 for details relating to investment
risks.
A copy of this Prospectus is available for
inspection at the registered office of the
Company at Level 1, 1 Alvan Street, Subiaco
WA 6008, during normal business hours. The
Prospectus will also be made available in
electronic form. Persons having received a
copy of this Prospectus in its electronic form
may obtain an additional paper copy of this
Prospectus (free of charge) from the
Company’s registered office by contacting the
Company. The Offers contemplated by this
Prospectus are only available in electronic form
to persons receiving an electronic version of
this Prospectus within Australia.
The Company will also provide copies of other
documents on request free of charge (see
Section 5.2).
This Prospectus is a “transaction specific”
prospectus for an offer of options to acquire
continuously quoted securities and has been
prepared in accordance with section 713 of the
Corporations Act. It does not contain the same
level of disclosure as an initial public offering
prospectus and is only required to contain,
amongst other things, information in relation to
the effect of the issue of securities on a
company and the rights attaching to the
securities. It is not necessary to include general
information in relation to all of the assets and
liabilities, financial position, profits and losses
or prospects of the issuing company.
No person is authorised to give any information
or to make any representation in connection
with the Offers in this Prospectus. Any
information or representation not so contained
may not be relied on as having been authorised
by the Company or the Directors in connection
with the Offers.
No investment advice
The information in this Prospectus is not
financial product advice and does not take into
account your investment objectives, financial
situation or particular needs. It is important that
you read this Prospectus in its entirety and seek
professional advice where necessary.
This document is important and should be read
in its entirety before deciding to participate in
the Offers.
Before making any investment in the Company,
each Applicant should consider whether such
an investment is appropriate to their particular
needs, and considering their individual risk
profile for speculative investments, investment
objectives and individual financial
circumstances. Each Applicant should consult
their stockbroker, solicitor, accountant or other
professional adviser without delay.
Disclosing entity
As a disclosing entity, the Company has issued
this Prospectus in accordance with section 713
of the Corporations Act applicable to
prospectuses for an offer of options to acquire
securities which are quoted enhanced
disclosure securities and the securities are in a
class of securities that were quoted enhanced
disclosure securities at all times in the three
months before the issue of this Prospectus.
This Prospectus is intended to be read in
conjunction with the publicly available
information in relation to the Company which
has been notified to the ASX and does not
include all the information that would be
included in a prospectus for an initial public
offering of securities in an entity that is not
already listed on a stock exchange. Investors
should therefore have regard to the other
publicly available information in relation to the
Company before making a decision about
whether to invest.
Having taken such precautions and having
made such enquiries as are reasonable, the
2
Company believes that it has complied with the
requirements of the ASX as applicable to
disclosing entities from time to time, and which
require the Company to notify ASIC of
information available to the stock market
conducted by the ASX, throughout the three
months before the issue of this Prospectus.
Information that is already in the public domain
has not been reported in this Prospectus other
than that which is considered necessary to
make this Prospectus complete.
Overseas Shareholders
The Offers constituted by this Prospectus in
electronic form is only available to persons
receiving an electronic version of this
Prospectus and accompanying Application
Form within Australia.
No action has been taken to permit the offer of
Quoted Options under this Prospectus in any
jurisdiction other than Australia.
The distribution of this Prospectus in
jurisdictions outside of Australia may be
restricted by law and persons who come into
possession of this Prospectus outside of
Australia should observe any such restrictions.
Any failure to comply with such restrictions may
constitute a violation of applicable securities
laws.
This Prospectus does not constitute an offer of
Quoted Options in any jurisdiction where, or to
any person to whom, it would be unlawful to
issue this Prospectus. In particular, this
Prospectus may not be distributed to any
person, and the Quoted Options may not be
offered or sold, in any country outside
Australia except to the extent permitted in
Section 1.14.
Target Market Determination
In accordance with the design and distribution
obligations under the Corporations Act, the
Company has determined the target market for
the offer of Quoted Options issued under this
Prospectus. The Company will only distribute
this Prospectus to those investors who fall
within the target market determination (TMD) as
set out on the Company’s website
(https://rarex.com.au/).
Forward-looking statements
This Prospectus includes forward looking
statements that have been based on current
expectations about future acts, events and
circumstances. These forward looking
statements are, however, subject to risks,
uncertainties and assumptions that could cause
those acts, events and circumstances to differ
materially from the expectations described in
the forward looking statements. The Directors
cannot and do not give any assurance that the
results, performance or achievements
expressed or implied by the forward-looking
statements contained in this Prospectus will
actually occur and investors are cautioned not
to place undue reliance on these forward-
looking statements. The Directors have no
intention to update or revise forward-looking
statements, or to publish prospective financial
information in the future, regardless of whether
new information, future events or any other
factors affect the information contained in this
Prospectus, except where required by law.
Definitions, time and currency
Definitions of certain terms used in this
Prospectus are contained in Section 7.
All references to currency are to Australian
dollars and all references to time are to AWST,
unless otherwise indicated.
Revenues and expenditures disclosed in this
Prospectus are recognised exclusive of the
amount of goods and services tax, unless
otherwise disclosed.
1
Corporate directory
Directors
Jeremy Robinson Non-Executive Chairman
James Durrant Managing Director & Chief Executive Officer
Danny Goeman Non-Executive Director
Shaun Hardcastle Non-Executive Director
Company Secretary
Oonagh Malone
Registered Office Share Registry*
Level 1, 1 Alvan Street
Subiaco WA 6008
Phone: +61 (08) 6383 6593
Email: info@rarex.com.au
Website: https://rarex.com.au/
Automic Pty Ltd
Level 5, 191 St Georges Terrace
Perth WA 6000
Auditor* Solicitors
Hall Chadwick WA Audit Pty Ltd
283 Rokeby Road
Subiaco WA 6008
Hamilton Locke Pty Ltd
Central Park Building
Level 39, 152–158 St Georges Terrace
Perth WA 6000
ASX Code: REE
* These entities are included for information purposes only. They have not been involved in the
preparation of this Prospectus.
2
Indicative timetable
Event Date
Lodgement of Prospectus with ASIC 20 October 2025
(post-market close)
Opening Date of Offers 21 October 2025
Closing Date of Offers (5:00pm AWST) 21 October 2025
Anticipated date of issue of Quoted Options
Lodgement of Appendix 2A applying for Official Quotation of Quoted
Options
22 October 2025
Anticipated date for commencement of Quoted Options trading on a normal
settlement basis
23 October 2025
Note: The above dates are indicative only and may change without notice. The Company reserves the right to vary
any and all of the above dates without notice, subject to the Corporations Act, Listing Rules and other applicable
laws. In particular, the Company reserves the right to vary the Opening Date and the Closing Date without prior
notice, which may have a consequential effect on the other dates. Applicants are therefore encouraged to lodge
their Application Form as soon as possible after the Opening Date if they wish to invest in the Company. The
Company also reserves the right not to proceed with the Offers at any time before the issue of Quoted Options.
3
Key details of the Offers
Size A maximum of 106,818,181 Quoted Options.
Issue price Nil.
Eligibility to participate in
the Offers
• May Placement Options Offer – the May Placement Options
Offer is open to May Placement Participants only. May
Placement Participants will be entitled to apply for Quoted
Options under the May Placement Options Offer, on the basis
of one (1) Quoted Option for every two (2) May Placement
Shares subscribed for and issued under the May Placement.
• July Placement Options Offer – the July Placement Options
Offer is open to July Placement Participants only. July
Placement Participants will be entitled to apply for Quoted
Options under the July Placement Options Offer, on the basis
of one (1) Quoted Option for every two (2) July Placement
Shares subscribed for and issued under the July Placement.
Capital structure
Indicative capital structure
Securities on issue as at the Prospectus Date
Shares 1,010,391,292
Performance Rights1 80,000,000
Options2 108,500,000
Securities on issue on completion of the Offers3
Shares4 1,014,482,199
Performance Rights 80,000,000
Options
• Unquoted Options5 123,500,000
• Quoted Options3,6 106,818,181
• Total 230,318,181
Notes:
1. Subject to the satisfaction of various performance conditions and expiring on various dates between 10
February 2026 and 13 October 2028.
2. 108,500,000 Unquoted Options, comprising:
(a) 33,000,000 Options exercisable at $0.018 each and expiring on 27 December 2027;
(b) 4,500,000 Options exercisable at $0.10 each and expiring on 1 March 2026;
(c) 15,000,000 Options exercisable at $0.025 each and expiring on 23 September 2028;
(d) 15,000,000 Options exercisable at $0.025 each (which vest upon a Prospecting Licence for the Mrima
Hill Project being granted to the Consortium) and expiring on 23 September 2028; and
(e) 41,000,000 Options exercisable at $0.046 each and expiring on 13 October 2028.
4
3. Assumes that the Offers are fully subscribed, and no further Securities are issued, other than as set out
below.
4. Assumes that the remaining 681,816 July Tranche 2 Placement Shares and the Director Placement Shares
are issued (as approved by Shareholders at the General Meeting).
5. Assumes that the Joint Lead Manager Options are issued (as approved by Shareholders at the General
Meeting).
6. See Section 4.2 for the terms and conditions of the Quoted Options. The issue of the Quoted Options is
conditional upon (amongst other things) ASX agreeing to grant Official Quotation of the Quoted Options on
ASX by the time required under the Corporations Act (subject to compliance with the requirements of ASX
and the Listing Rules for the quotation of a new class of securities). If this condition is not satisfied, then the
Offers will not proceed. See Section 1.4 for further information.
Investment overview
This Section is intended to highlight key information for potential investors. It is an overview only, and
is not intended to replace the Prospectus.
Potential investors should read the Prospectus in full before deciding to invest in Quoted Options.
Key Information Further
Information
Transaction specific prospectus
This Prospectus is a transaction specific prospectus for an offer of options to acquire
continuously quoted securities (as defined in the Corporations Act) and has been
prepared in accordance with section 713 of the Corporations Act. It does not contain
the same level of disclosure as an initial public offering prospectus. In making
representations in this Prospectus regard has been had to the fact that the Company
is a disclosing entity for the purposes of the Corporations Act and certain matters may
reasonably be expected to be known to investors and professional advisers whom
potential investors may consult.
-
What are the Offers being made under the Prospectus?
By this Prospectus, the Company is offering:
• up to 61,363,636 Quoted Options to May Placement Participants, on the basis of
one (1) free-attaching Quoted Option for every two (2) May Placement Shares
subscribed for and issued under the May Placement (May Placement Options
Offer); and
• up to 45,454,545 Quoted Options to July Placement Participants, on the basis of
one (1) free-attaching Quoted Option for every two (2) July Placement Shares
subscribed for and issued under the July Placement (July Placement Options
Offer),
(together, the Offers).
Section 1.3
What is the purpose of this Prospectus?
The primary purpose of this Prospectus is to:
• make the offers of Quoted Options under the May Placement Options Offer and
the July Placement Options Offer; and
• ensure that the on-sale of the Shares issued on conversion of the Quoted Options
do not breach section 707(3) of the Corporations Act.
Section 1.5
2
Key Information Further
Information
What is the intended use of funds from the Offers?
No funds will be raised from the issue of the Quoted Options under the May Placement
Options Offer and July Placement Options Offer as the May Placement Options and
July Placement Options are free-attaching to the May Placement Shares and July
Placement Shares issued under the May Placement and July Placement.
Section 2.2
Who is eligible to subscribe under the Offers?
• May Placement Options Offer – the May Placement Options Offer is open to May
Placement Participants only.
• July Placement Options Offer – the July Placement Options Offer is open to July
Placement Participants only.
Section 1.3
What are the terms of the Quoted Options?
The Quoted Options will be exercisable at $0.035 each and will expire three (3) years
from the date of issue.
The full terms of the Quoted Options are set out in Section 4.2.
Section 4.2
Are the Offers underwritten?
The Offers are not underwritten.
Section 1.8
What is the effect of the Offers?
The effect of the Offers on the capital structure is set out below (refer to Section 2.1 for
further details about the assumptions underpinning the table):
Indicative capital structure
Securities on issue as at the Prospectus Date
Shares 1,010,391,292
Performance Rights 80,000,000
Options 108,500,000
Securities on issue on completion of the Offers3
Shares 1,014,482,199
Performance Rights 80,000,000
Options
• Unquoted Options 123,500,000
• Quoted Options 106,818,181
• Total 230,318,181
Section 2
3
Key Information Further
Information
It is not expected that the Offers will have any effect on the control of the Company.
The Company does not consider that the Offers will have a material effect on the
financial position of the Company. The expenses of the Offers will be met from the
Company’s existing cash reserves. The Offers will have an effect on the Company's
financial position of reducing the cash balance by approximately $51,763. Please refer
to Section 5.10 for further details on the estimated expenses of the Offers.
What are the risks of a further investment in the Company?
Potential investors should be aware that subscribing for Quoted Options in the
Company involves a number of risks. The key risk factors of which investors should be
aware are set out in Section 3, including (but not limited to) risks in respect of:
• Future capital requirements: The Company has no operating revenue and is
unlikely to generate any operating revenue unless and until its projects are
successfully developed and production commences. The future capital
requirements of the Company will depend on many factors including its business
development activities. Should the Company require additional funding, there can
be no assurance that additional financing will be available on acceptable terms or
at all. Any inability to obtain additional financing, if required, would have a material
adverse effect on the Company's business, financial condition and results of
operations.
• Title risk: The Company’s tenement portfolio is governed by the Mining Act 1978
(Cth), and related subsidiary legislation, which requires annual expenditure and/or
reporting commitments, as well as other conditions requiring compliance.
• Exploration and development risks: Mineral exploration and development are
high-risk undertakings. There can be no assurance that exploration of acquired
projects or any other exploration properties that may be acquired in the future will
result in the discovery of an economic resource. Even if an apparently viable
resource is identified, there is no guarantee that it can be economically exploited.
• Operating risks: The operations of the Company may be affected by various
factors, including failure to locate or identify mineral deposits, failure to achieve
predicted grades in exploration and mining, operational and technical difficulties
encountered in mining; difficulties in commissioning and operating plant and
equipment, mechanical failure or plant breakdown, unanticipated metallurgical
problems which may affect extraction costs; adverse weather conditions, industrial
and environmental accidents, industrial disputes and unexpected shortages or
increases in the costs of consumables, spare parts, plant and equipment.
• Commodity price volatility: The Company's ability to proceed with the
development of its rare earth, phosphate and niobium projects and benefit from
any future mining operations will depend on market factors, some of which may be
beyond its control. It is anticipated that any revenues derived from mining will
primarily be derived from the sale of rare earths, phosphate and other minerals.
Consequently, any future earnings are likely to be closely related to the price of
this commodity and the terms of any off-take agreements that the Company enters
into.
• Native title and Aboriginal heritage risks: The Native Title Act 1993 (Cth)
recognises and protects the rights and interests in Australia of Aboriginal and
Torres Strait Islander people in land and waters, according to their traditional laws
and customs. There is significant uncertainty associated with native title in Australia
and this may impact on the Company's operations and future plans by delaying,
restricting or prohibiting access to tenements.
Section 3
4
Key Information Further
Information
• Environmental risks: Mining operations have inherent risks and liabilities
associated with safety and damage to the environment and the disposal of waste
products occurring as a result of mineral exploration and production. The
occurrence of any such safety or environmental incident could delay production or
increase production costs. Events, such as unpredictable rainfall or bushfires may
impact on the Company’s ongoing compliance with environmental legislation,
regulations and licences. Significant liabilities could be imposed on the Company
for damages, clean-up costs or penalties in the event of certain discharges into the
environment, environmental damage caused by previous operations or
noncompliance with environmental laws or regulation.
• Access, permits and approvals: In order to undertake mineral exploration on the
Company’s tenements, the Company has various access deeds in place and will
seek to implement others in key areas of the Company’s projects as and when it
determines that activities should be undertaken.
Certain mineral rights and interests to be held by the Company are subject to the
need for ongoing or new government approvals and permits. These requirements,
including work permits and environmental approvals, will change as the Company’s
activities develop. Delays in obtaining, or the inability to obtain, required
authorisations may significantly impact on the Company's operations. The
Company’s capacity to undertake future mining operations in its Tenement area
will be affected by various factors such as:
(i) potential inability to obtain necessary consents and approvals to mine;
(ii) delay to obtaining necessary consents and approvals to mine;
(iii) increased costs in obtaining necessary consents and approvals to mine; and
(iv) limited ground available for mining due to access restrictions and limitations.
• Quotation risk: The Company will apply for quotation of the Quoted Options
subject to compliance with the requirements of ASX and the Listing Rules. The
Company makes no guarantee that any such application for quotation will be
successful and there is a risk that the Company will not be able to satisfy the ASX
requirements for quotation. In the event that the Company is unable to satisfy the
ASX requirements, the Quoted Options will still be issued, but will be Unquoted
Options and there will be no public market for the Quoted Options. If the Quoted
Options are admitted to official quotation by ASX, the price of the Quoted Options
is subject to uncertainty and there can be no assurance that an active market for
the Quoted Options will develop or continue after the Offers.
• Option risk and dilution: Options are, by their nature, only of value at times when
the exercise price is lower than the price of the underlying Shares. There is no
guarantee that the Quoted Options offered under this Prospectus will, at any
particular time, have an exercise price which is lower than the price of the Shares.
There is a risk that the Quoted Options may expire at a time when they have little
or no value. On completion of the Offers, assuming the Offers are fully subscribed,
there will be up to 106,818,181 Quoted Options on issue. If exercised, these
Quoted Options will be converted into Shares, thereby causing the shareholdings
of Shareholders to be diluted by up to 9.53% (on the basis that the Offers are fully
subscribed and no other Securities are issued or exercised at the date of this
Prospectus, other than the issues of Securities approved by Shareholders at the
General Meeting as set out in Section 2.1).
• General market risks: Share market conditions may affect the value of the
Company's Securities regardless of the Company's operating performance. The
5
Key Information Further
Information
Company is exposed to general market and economic condition risks including
adverse changes in levels of economic activity, exchange rates, interest rates,
commodity prices, government policies, employment rates and industrial
disruption.
Forward looking statements
This Prospectus contains forward-looking statements which are identified by words
such as ‘may’, ‘could’, ‘believes’, ‘estimates’, ‘targets’, ‘expects’, or ‘intends’ and other
similar words that involve risks and uncertainties.
These statements are based on an assessment of present economic and operating
conditions, and on a number of assumptions regarding future events and actions that,
as at the date of this Prospectus, are considered reasonable.
Such forward-looking statements are not guarantees of future performance and involve
known and unknown risks, uncertainties, assumptions and other important factors,
many of which are beyond the control of the Company, the Directors and the
management.
The Directors cannot and do not give any assurance that the results, performance or
achievements expressed or implied by the forward-looking statements contained in this
Prospectus will actually occur and investors are cautioned not to place undue reliance
on these forward-looking statements.
The Directors have no intention to update or revise forward-looking statements, or to
publish prospective financial information in the future, regardless of whether new
information, future events or any other factors affect the information contained in this
Prospectus, except where required by law.
These forward-looking statements are subject to various risk factors that could cause
the Company’s actual results to differ materially from the results expressed or
anticipated in these statements. These risk factors are set out in Section 3.
Section 3
6
1. Background to the Offers
1.1 May Placement
On 14 May 2025, the Company announced a capital raising of $2.7 million (before costs) via
the issue of:
(a) up to 122,727,274 Shares to new and existing sophisticated, professional and other
exempt investors (May Placement Participants) at an issue price of $0.022 per Share
(May Placement Shares); and
(b) up to 61,363,636 Quoted Options to the May Placement Participants (May Placement
Options) on the basis of one May Placement Option for every two (2) May Placement
Shares subscribed for and issued under the May Placement,
(together, the May Placement).
The May Placement is comprised of the following tranches:
(a) Tranche 1: the issue of 119,318,183 May Placement Shares utilising the Company’s
available placement capacity under Listing Rule 7.1 (May Tranche 1 Placement
Shares); and
(b) Tranche 2: comprising the issue of:
(i) subject to Shareholder approval under Listing Rule 7.1, up to 59,659,091 May
Placement Options to unrelated parties of the Company; and
(ii) subject to Shareholder approval under Listing Rule 10.11, up to 3,409,091 May
Placement Shares (Director Placement Shares) and 1,704,545 May
Placement Options (Director Placement Options) to the Participating
Directors (or their respective nominees).
On 22 May 2025, the Company issued the May Tranche 1 Placement Shares without prior
Shareholder approval under Listing Rule 7.1.
At the Company’s general meeting of Shareholders held on 23 September 2025 (General
Meeting), the Company sought and obtained Shareholder approval to issue the May Placement
Options (including the Director Placement Options) and Director Placement Shares.
1.2 July Placement
On 21 July 2025, the Company announced a capital raising of $2 million (before costs) via the
issue of:
(a) up to 90,909,091 Shares to new and existing sophisticated, professional and other
exempt investors (July Placement Participants) at an issue price of $0.022 per Share
(July Placement Shares); and
(b) up to 45,454,545 Quoted Options to the July Placement Participants (July Placement
Options) on the basis of one July Placement Option for every two (2) July Placement
Shares subscribed for and issued under the July Placement,
(together, the July Placement).
7
The July Placement is comprised of the following tranches:
(a) Tranche 1: the issue of 79,999,998 July Pla
Share your feedback
Discover